FAQ Frequently Asked Questions

Bains Consulting is a pharmaceutical consulting firm that works from concept to commercialization. We provide advisory and hands-on operational support across formulation development, facility design and engineering, regulatory compliance, quality systems, scale-up, and commercialization. The firm was founded to bridge the gap between pharmaceutical innovation and successful execution.

Pharmaceutical consulting is advisory and execution support for organizations that develop, manufacture, compound, or distribute medications — covering formulation, facilities, equipment, quality systems, regulatory compliance, and commercial operations. Bains Consulting delivers that work hands-on, from concept through commercialization.

Pharmaceutical companies, 503A compounding pharmacies, 503B outsourcing facilities, drug manufacturers, telemedicine organizations, specialty and veterinary pharmacies, wellness brands, private equity firms, and international healthcare organizations.

More than 25 years of hands-on experience, 13+ pharmacies built, acquired and sold, and pharmacy and DEA licensing experience across 50 states. We are former owner/operators rather than career consultants, with USP 795, 797 and 800 expertise, sterile and non-sterile formulation experience, telemedicine fulfillment scale-up, and original pharmaceutical IP as a patent holder.

Yes — end to end: concept, development, scale-up, and market. That covers sterile and non-sterile product development, analytical method development and validation, pilot manufacturing, technology transfer, process validation at commercial scale, and the batch records, SOPs, and operator training required to run the process. See formulation development and scale-up & commercialization.

Scale-up is a sequence, not a single step: confirm the formulation and its analytical methods, run pilot batches, select and qualify equipment, transfer the process, validate it at commercial scale, then lock in batch records, SOPs, and operator training.

Yes. We specify, source, and qualify equipment for every dosage form — solid dose (tablet presses, granulators, fluid bed dryers, blenders, mills, coating systems), sterile (isolators, filling lines, lyophilizers, depyrogenation ovens), and compounding (unguators, planetary mixers, homogenizers, ODT and troche equipment) — together with URS development, FAT/SAT, IQ/OQ/PQ, validation, and training.

Yes. Engage us for a single mandate or the entire build — and the regulatory rigor in between. We also deliver turnkey pharmacy solutions, from business planning and facility buildout through equipment procurement, validation, training, regulatory readiness, and go-live support.

Yes. Our Training Academy covers compounding (USP 795, 797, 800), quality (CAPA, investigations, auditing), regulatory (FDA, DEA, Board of Pharmacy), and leadership (operations management, facility management, scale-up strategy).

Yes — both are core audiences. For 503A pharmacies we cover licensing, facility design to USP 795 and 800, workflow design, HVAC review, equipment, SOPs, and staffing. For 503B outsourcing facilities we cover cGMP design, sterile suites, cleanroom design, environmental monitoring, equipment, and quality systems.

A 503A pharmacy compounds patient-specific prescriptions under state board of pharmacy oversight and USP 795, 797 and 800 standards. A 503B outsourcing facility registers with the FDA, can compound batches for office stock without patient-specific prescriptions, and is expected to operate under cGMP. The two models differ in licensing, facility design, quality systems, and documentation.

Yes. We have built end-to-end fulfillment operations capable of processing more than 100,000 prescriptions daily through automation, optimized workflows, staffing strategy, and production planning, and have reduced turnaround time by up to 80% through process redesign, automation, workflow optimization, and capacity planning.

Yes. We have supported complex licensing strategies, regulatory compliance, inspection readiness, and operational expansion across multiple U.S. jurisdictions, with pharmacy and DEA licensing experience across 50 states — including new licensure, change of ownership, non-resident licensing, DEA registration, security reviews, and controlled substance programs.

Facility design starts with workflow and capacity — which dosage forms, what volumes, and what level of sterility. From there it covers room layout and classification, HVAC and pressure cascades, mechanical, electrical and plumbing coordination, finishes, equipment placement, environmental monitoring, and the documentation required for licensure and inspection.

Yes. We provide compliant facility design and engineering, from 503A pharmacies to 503B sterile suites — facility layout, cleanroom design, environmental monitoring, and mechanical, electrical, plumbing, HVAC and pressure-cascade engineering. We have designed, engineered, and launched a 200,000 sq. ft. commercial pharmaceutical operation including 503A sterile and non-sterile production, fulfillment, warehousing, and supporting infrastructure.

We prepare operations the way an investigator reviews them — quality systems, SOPs, documentation practices, environmental monitoring, CAPA and investigations — and support Form 483 and warning letter responses. Inspection outcomes are determined by the agency; our role is readiness, not a guaranteed result.

USP 795, 797 and 800 compliance is core expertise. It runs through 503A facility design, sterile and non-sterile operations, quality systems, and our professional training programs in compounding, quality, regulatory, and leadership.

QA and QC programs built to withstand inspection and protect product quality — SOP development, training programs, internal audits and supplier qualification on the QA side; potency, stability, environmental monitoring and water activity programs on the QC side; plus CAPA, change control, deviations, investigations, complaint handling, and recall programs.

Yes. We empower modern pharmaceutical operations through ERP, AI, automation, advanced analytics, and connected digital ecosystems that improve operational efficiency, compliance, and decision-making — ERP strategy, selection, integration and implementation, AI workflow automation, machine vision and barcode verification, inventory automation, data warehousing, business intelligence dashboards, and KPI analytics.

Yes. Telemedicine companies are one of the audiences we serve, and telemedicine fulfillment scale-up is part of our hands-on experience. We build telemedicine infrastructure including provider networks, ePrescribing integration, and pharmacy fulfillment, plus onboarding, client success, and fulfillment optimization.

Our case studies include a 200,000 sq. ft. pharmaceutical operation designed, engineered and launched; fulfillment scaled beyond 100,000 prescriptions per day; turnaround time reduced by up to 80%; multi-state licensing support across 50 states; and commercial-ready formulations transferred from R&D through pilot manufacturing into scalable commercial production.